Related Experiment Video
Updated: Jul 10, 2026

A High-content Assay for Monitoring AMPA Receptor Trafficking
Published on: January 28, 2019
TARP auxiliary subunits switch AMPA receptor antagonists into partial agonists
Karen Menuz1, Robert M Stroud, Roger A Nicoll
1Department of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, CA 94143, USA.
The common AMPA receptor antagonist CNQX acts as a partial agonist when transmembrane AMPA receptor regulatory proteins (TARPs) are present. TARPs enhance CNQX
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Quinoxalinedione compounds, like 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), are widely used as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists.
- Transmembrane AMPA receptor regulatory proteins (TARPs) are crucial auxiliary subunits modulating AMPA receptor function.
Purpose of the Study:
- To investigate the functional role of TARPs in modulating the activity of CNQX at AMPA receptors.
- To elucidate the mechanism by which TARPs influence the agonist/antagonist properties of CNQX.
Main Methods:
- Electrophysiological recordings in neurons of the central nervous system to measure CNQX-induced currents.
- Coexpression studies involving AMPA receptors and TARPs.
- Crystal structure analysis of CNQX bound to the TARP-less AMPA receptor ligand-binding domain.
Main Results:
- CNQX induced small depolarizing currents in neurons, indicating partial agonist activity in the presence of TARPs.
- This agonist activity was dependent on the coexpression of TARPs.
- Crystal structure revealed that while CNQX causes partial domain closure in the absence of TARPs, this is not transduced into channel opening, suggesting TARPs strengthen this coupling.
Conclusions:
- The presence of AMPA receptor auxiliary subunits (TARPs) can fundamentally alter the pharmacological profile of a compound, switching it from antagonist to partial agonist.
- TARPs play a critical role in enhancing the efficacy of partial agonists by improving the transduction of ligand binding to channel gating.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Desensitization and Tachyphylaxis
Several...
GPCR Desensitization
Opioid Receptors: Overview